Study title: A study of the efficacy and safety of repeated nebulized therapy combining ipratropium bromide 0.25 mg plus salbutamol sulphate 3.0 mg versus salbutamol sulphate 3.0 mg alone in children with acute asthma
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases [C08] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: IPRATROPIUM | |||||
ATC code: | |||||
Document link: Ipratropium bromide_U94-0664_synopsis.pdf | |||||
Document date: 2011-09-22 | |||||
Study number: U94-0664 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |